HBIO today
$9.46+$0.25 (+2.66%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bullish
1 hourStrong Bullish
15 minLeaning Bearish
5 minSymmetric Triangle
Daily trend turns up above $23.19
Key levels
Resistance$19.90
Resistance$10.20
Support$9.10
Support$8.11
Latest news & SEC filings
AnalystHarvard Bioscience cut to Hold at StoneX
EarningsHarvard Bioscience Posts Q3 2026 Results
EarningsHarvard Bioscience holds Q3 2026 earnings call
GuidanceHarvard Bioscience lifts FY2026 sales guidance to $89.147M-$90.877M
All HBIO news →About Harvard Bioscience
Harvard Bioscience provides scientific instruments, software, and consumables used in laboratory research, medicine development, and testing of therapies before human trials. Its tools cover cell and organoid work, including electroporation devices, pumps, and analyzers, as well as systems for monitoring animals such as telemetry, breathing, and behavior equipment. Buyers include universities, government labs, drugmakers, biotech firms, and research contractors. Sales happen directly and via distributors across North America, Europe, and Asia.
Based on the company's 10-K filed Mar 13, 2026.
Nasdaq · Technology
HARVARD BIOSCIENCE INC (HBIO)
What Is the Price Target for HBIO?
SEPT Low Target
$7.50
SEPT Mid Target
$7.50
SEPT High Target
$7.50
Analyst Consensus
$7.50
Is HBIO a Buy or Sell Right Now?
Thesis
- •Revenue growing -8.1% YoY with DECLINING trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HBIO.
Start Free Trial →Is HBIO Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
Analyst Consensus
Fair Value
$7.50
15
Moat Score
NONE
4/9
Piotroski Score
-0.9
Altman Z-Score
What Is Smart Money Doing with HBIO?
Insider Signal
NEUTRAL
3 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Snider William | director | Buy | 16,556 | - | Jun 9, 2026 |
| DENELSKY STEPHEN J | director | Buy | 16,556 | - | Jun 9, 2026 |
| Gagnon Robert E. | director | Buy | 16,556 | - | Jun 9, 2026 |
| Benson Seth Benjamin | director | Buy | 16,556 | - | Jun 9, 2026 |
| Eade Katherine A. | director | Buy | 16,556 | - | Jun 9, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HBIO Growth Story
Revenue YoY
-8.1%
3yr Revenue CAGR
-8.6%
EPS Growth YoY
-357.14%
FCF Growth YoY
554.4%
Revenue Trend
DECLINING
Dark Pool Trades for HBIO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HBIO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:06:25 | $9.54 | 1,350 | $$13K | SELL |
| 16:05:55 | $9.56 | 1,500 | $$14K | BUY |
| 15:58:52 | $9.46 | 1,500 | $$14K | BUY |
| 16:09:43 | $9.72 | 1,000 | $$10K | BUY |
| 20:36:07 | $9.48 | 1,633 | $$15K | SELL |
5 dark pool trades shown · $$67K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for HARVARD BIOSCIENCE INC (HBIO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (7 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HBIO — frequently asked questions
What is HBIO stock price today?
HARVARD BIOSCIENCE INC (HBIO) is at $9.46, up 2.66% (+$0.25) at the Nov 13, 2026 close.
Why is HBIO stock moving today?
Latest HBIO news — Nov 11, 2026: Harvard Bioscience cut to Hold at StoneX · Nov 10, 2026: Harvard Bioscience Posts Q3 2026 Results
Why did HBIO stock move on Nov 10, 2026?
Harvard Bioscience reported Q3 2026 results with an adjusted loss of 6 cents per share, narrower than the 17-cent loss analysts expected, and revenue of $22.196 million that beat the $21.800 million consensus. The company also raised its full-year 2026 sales guidance to $89.147M-$90.877M from $88.281M-$90.012M, though its Q4 sales guidance of $23.7M-$25.5M has a midpoint below the $24.5M estimate.
What is the HBIO price target?
The average analyst price target for HBIO is $7.50, ranging from $8 to $8, based on 1 analysts. Latest: Benchmark maintains on Aug 12, 2026.
What do analysts rate HBIO?
Analyst ratings for HBIO: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did HBIO beat earnings?
HBIO last reported on Nov 10, 2026: EPS -$0.06 vs -$0.17 expected — a beat of 64.7%.
What is HBIO's P/E ratio?
HBIO trades at a P/E of 1.0 vs a Technology average of 28.1.
Does HBIO pay a dividend?
HBIO does not currently pay a dividend.
How much debt does HBIO have?
HARVARD BIOSCIENCE INC reported $37M of debt and $7M of cash (Jun 30, 2026).
What are HBIO support and resistance levels?
Support: $9.10, $8.11, $7.36. Resistance: $10.20, $19.90, $23.19.
What are insiders doing with HBIO?
Insider activity: NEUTRAL, 3 buys and 0 sells in the last 90 days.
What is the latest news on HBIO?
Nov 11, 2026: Harvard Bioscience cut to Hold at StoneX · Nov 10, 2026: Harvard Bioscience Posts Q3 2026 Results · Nov 10, 2026: Harvard Bioscience holds Q3 2026 earnings call